ECSP045322A - Formulaciones de un anhidrato en suspensión con hfa - Google Patents

Formulaciones de un anhidrato en suspensión con hfa

Info

Publication number
ECSP045322A
ECSP045322A EC2004005322A ECSP045322A ECSP045322A EC SP045322 A ECSP045322 A EC SP045322A EC 2004005322 A EC2004005322 A EC 2004005322A EC SP045322 A ECSP045322 A EC SP045322A EC SP045322 A ECSP045322 A EC SP045322A
Authority
EC
Ecuador
Prior art keywords
hfa
hid
formulations
suspension
hydroxidi
Prior art date
Application number
EC2004005322A
Other languages
English (en)
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP045322A publication Critical patent/ECSP045322A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EC2004005322A 2002-03-28 2004-09-28 Formulaciones de un anhidrato en suspensión con hfa ECSP045322A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats

Publications (1)

Publication Number Publication Date
ECSP045322A true ECSP045322A (es) 2005-01-28

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005322A ECSP045322A (es) 2002-03-28 2004-09-28 Formulaciones de un anhidrato en suspensión con hfa

Country Status (21)

Country Link
EP (1) EP1492498A2 (fr)
JP (1) JP5147158B2 (fr)
KR (1) KR101005717B1 (fr)
CN (1) CN1642525A (fr)
AU (1) AU2003221509B2 (fr)
BR (1) BR0308709A (fr)
CA (1) CA2479638C (fr)
DE (1) DE10214264A1 (fr)
EA (1) EA008610B1 (fr)
EC (1) ECSP045322A (fr)
HR (1) HRP20040890A2 (fr)
IL (1) IL163696A0 (fr)
ME (1) ME00246B (fr)
MX (1) MXPA04009338A (fr)
NO (1) NO20044004L (fr)
NZ (1) NZ536030A (fr)
PL (1) PL371295A1 (fr)
RS (1) RS52481B (fr)
UA (1) UA79776C2 (fr)
WO (1) WO2003082244A2 (fr)
ZA (1) ZA200405637B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5227790B2 (ja) * 2005-05-02 2013-07-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規結晶性臭化チオトロピウム
EP1879888A2 (fr) * 2005-05-02 2008-01-23 Boehringer Ingelheim International GmbH Formes cristallines de bromure de tiotropium
AU2010253770B9 (en) * 2009-05-29 2015-02-12 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
EP3515439B1 (fr) * 2016-09-19 2021-12-15 Mexichem Fluor S.A. de C.V. Composition pharmaceutique comprenant du bromure de tiotropium

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP1102579B1 (fr) * 1998-08-04 2003-03-19 Jago Research Ag Formulations d'aerosol a usage medical
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten
JP2004512379A (ja) * 2000-10-31 2004-04-22 ベーリンガー　インゲルハイム　ファルマ　ゲゼルシャフト　ミット　ベシュレンクテル　ハフツング　ウント　コンパニー　コマンディトゲゼルシャフト 新規医薬組成物
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten

Also Published As

Publication number Publication date
JP5147158B2 (ja) 2013-02-20
MXPA04009338A (es) 2005-01-25
IL163696A0 (en) 2005-12-18
WO2003082244A3 (fr) 2004-02-05
KR20040098022A (ko) 2004-11-18
NO20044004L (no) 2004-10-05
AU2003221509A1 (en) 2003-10-13
CA2479638C (fr) 2011-01-04
EP1492498A2 (fr) 2005-01-05
EA008610B1 (ru) 2007-06-29
MEP47308A (en) 2011-02-10
CN1642525A (zh) 2005-07-20
PL371295A1 (en) 2005-06-13
ME00246B (fr) 2011-05-10
RS52481B (sr) 2013-02-28
AU2003221509B2 (en) 2008-01-24
EA200401159A1 (ru) 2005-04-28
KR101005717B1 (ko) 2011-01-05
JP2005527550A (ja) 2005-09-15
BR0308709A (pt) 2005-01-04
YU86004A (sh) 2006-08-17
WO2003082244A2 (fr) 2003-10-09
CA2479638A1 (fr) 2003-10-09
ZA200405637B (en) 2005-07-27
DE10214264A1 (de) 2003-10-16
NZ536030A (en) 2006-07-28
UA79776C2 (en) 2007-07-25
HRP20040890A2 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
BR0116444A (pt) Processo para a preparação de brometo de tiotrópio anticolinérgico
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
FI903331A0 (fi) Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
MY132129A (en) Polyarylcarboxamides useful as lipid lowering agents
TW200738672A (en) Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
MX9304646A (es) Nuevas 7-(sustituido)-8-(sustituido)d-9-[(glicilo sustituido)amido]-6-desmetil-6-desoxitetraciclinasy metodo para su produccion.
MXPA03009602A (es) Analogos de nociceptina.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
ECSP045321A (es) Formulaciones en suspensión con hfa que contienen un anticolinérgico
MXPA04003755A (es) Endoprotesis vasculares.
BR0115139A (pt) Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante
BR0308709A (pt) Formulações em suspensão de hfa de um anidrato
DE60112325D1 (de) Cyclisierungsverfahrensschritt bei der herstellung von chinolonen und naphthyridinen
IL150310A0 (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
BR9916460A (pt) Produção de ácido ascórbico usando levedura
ATE243362T1 (de) Phosphor-überzug für gasentladungslampen
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
GB2348423B (en) Novel anhydrofructose antioxidant
ES2093760T3 (es) Procedimiento para la obtencion de fosfinas terciarias.
WO2003033498A3 (fr) Procede de preparation de l'intermediaire n2-acetyl-9-(1,3-diacetoxy-2-propoxymethyl) guanine du ganciclovir
GB9921578D0 (en) Omeprazole synthesis
TW200620379A (en) Lamp
AU2002339174A1 (en) Light emitting device and compounds for use therein
NO20011578L (no) Anvendelse av acylkarnitiner som antitumormidler